Anti-Human Ganglioside GD4 Recombinant Antibody(Mitumomab)
-
产品编号
YR1070
-
别名
科研级 Mitumomab ( 米妥莫单抗 ), Anti-Ganglioside GD4 Recombinant Antibody, Research Grade Mitumomab
-
规格
- 1mg
- 5mg
Alias | 科研级 Mitumomab ( 米妥莫单抗 ), Anti-Ganglioside GD4 Recombinant Antibody, Research Grade Mitumomab |
Catalog Number | YR1070 |
Molecular Name | Mitumomab |
Host | Mouse |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG2b Kappa |
Formulation | PBS, pH7.5 |
Background | Mitumomab (BEC-2) is a mouse anti-BEC-2 monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination. Mitumomab attacks tumour cells, while the vaccine is thought to activate the immune system. It was developed by ImClone and Merck. |
CAS Number | 216503-58-1 |
Application | ELISA, FCM, IP, FuncS, IF, Neut, ICC |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | Ganglioside GD4[Homo sapiens] |